Cytokinetics Inc (NASDAQ:CYTK)

8.03
Delayed Data
As of 10:07am ET
 +0.08 / +1.01%
Today’s Change
3.05
Today|||52-Week Range
13.26
+0.25%
Year-to-Date

Stock Price Forecast

The 5 analysts offering 12-month price forecasts for Cytokinetics Inc have a median target of 14.00, with a high estimate of 18.00 and a low estimate of 9.00. The median estimate represents a +74.35% increase from the last price of 8.03.

Analyst Recommendations

The current consensus among 5 polled investment analysts is to Buy stock in Cytokinetics Inc. This rating has held steady since March, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.12
Sales
$10.1M
Reporting Date
May 05

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -152.17%
 
 
 
 
 
 
Growthannually -142.07%
 
 
 
 
 
 

Sales

Growthquarterly -53.74%
 
 
 
 
 
 
Growthannually -19.10%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.

To view my watchlist

Not a member yet?

Sign up now for a free account